NMDA Receptor

NMDA Receptor

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NMDA Receptor</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NMDA-RECEPTOR</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NMDA Receptor</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=NMDA-RECEPTOR" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>

The N-methyl-D-aspartate (NMDA) receptor is a ionotropic glutamate receptor that plays a critical role in synaptic plasticity, learning, and memory. NMDA receptors are voltage-dependent calcium channels that require both glutamate binding and membrane depolarization for activation. In neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), NMDA receptor dysregulation contributes to excitotoxicity, synaptic loss, and neuronal death. This page explores the structure, function, and therapeutic targeting of NMDA receptors in neurodegeneration. [@paoletti2013]

Structure and Subunit Composition

NMDA receptors are heteromeric complexes composed of multiple subunits: [@lau2007]

Core Subunits

NMDA Receptor

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NMDA Receptor</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NMDA-RECEPTOR</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NMDA Receptor</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=NMDA-RECEPTOR" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>

The N-methyl-D-aspartate (NMDA) receptor is a ionotropic glutamate receptor that plays a critical role in synaptic plasticity, learning, and memory. NMDA receptors are voltage-dependent calcium channels that require both glutamate binding and membrane depolarization for activation. In neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), NMDA receptor dysregulation contributes to excitotoxicity, synaptic loss, and neuronal death. This page explores the structure, function, and therapeutic targeting of NMDA receptors in neurodegeneration. [@paoletti2013]

Structure and Subunit Composition

NMDA receptors are heteromeric complexes composed of multiple subunits: [@lau2007]

Core Subunits

• [GRIN1](/genes/grin1) (GluN1): The essential subunit required for functional receptor formation. Multiple splice variants exist, including NR1-1a, NR1-1b, NR1-2a, and NR1-2b, which differ in their C-terminal domains and trafficking properties.
• [GRIN2A](/genes/grin2a) (GluN2A): Developmentally regulated, with higher expression in adulthood. NR2A-containing receptors are associated with synaptic localization and faster decay kinetics.
• [GRIN2B](/genes/grin2b) (GluN2B): Predominant in early development. NR2B-containing receptors exhibit slower decay kinetics and are often extrasynaptic. The GRIN2B gene encodes the NR2B subunit, which has been heavily studied in the context of memory and excitotoxicity.

Regulatory Subunits

• [GRIN3A](/proteins/grin3a-protein) (GluN3A): Acts as a dominant-negative regulator that reduces calcium permeability when incorporated into receptors.
• [GRIN3B](/genes/grin3b) (GluN3B): Expressed primarily in motor neurons and subpopulations of interneurons.

Structure-Function Relationships

The receptor consists of an extracellular N-terminal domain (NTD), a ligand-binding domain (LBD), a transmembrane domain (TMD) with three helices and one reentrant loop, and an intracellular C-terminal domain (CTD). The CTD interacts with numerous scaffolding proteins including PSD-95, which anchors receptors at synaptic sites. [@kalia2008]

Physiological Function

Synaptic Plasticity

NMDA receptors are the molecular substrate for long-term potentiation (LTP) and long-term depression (LTD), the cellular correlates of learning and memory. Calcium influx through NMDA receptors activates intracellular signaling cascades including CaMKII, calcineurin, and various transcription factors. [@clevenger2018]

Calcium Signaling

Upon activation, NMDA receptors allow influx of Ca²⁺ and Na⁺ while permitting efflux of K⁺. The calcium influx triggers: [@zhang2016]

• Activation of CaMKII autophosphorylation
• CREB-mediated gene transcription
• Nitric oxide synthesis
• Synaptic remodeling through actin cytoskeleton modification

Developmental Role

During critical periods of brain development, NMDA receptor subunit composition shifts from predominantly NR2B-containing to NR2A-containing receptors. This transition refines synaptic plasticity and stabilizes neural circuits. [@mota2019]

NMDA Receptor Dysfunction in Neurodegeneration

Excitotoxicity

Excessive glutamate release or prolonged NMDA receptor activation leads to excitotoxicity—a process characterized by: [@kandell2009]

Alzheimer's Disease

In AD, several mechanisms contribute to NMDA receptor dysregulation: [@hardinghan2006]

Amyloid-β (Aβ) Effects: Aβ oligomers directly interact with NMDA receptors, enhancing their activity at low concentrations while causing internalization at high concentrations. This dysregulation contributes to synaptic dysfunction. [@bull2015]

Tau Pathology: Hyperphosphorylated tau disrupts NMDA receptor trafficking and localization, shifting receptors to extrasynaptic locations where they promote pro-death signaling. [@xia2010]

Metabolic Dysfunction: Reduced glucose metabolism in AD brains impairs NMDA receptor function and energy-dependent processes like receptor trafficking. [@li2017]

Key findings from research:

• [Liu et al., 2010](https://pubmed.ncbi.nlm.nih.gov/20338386/) demonstrated that Aβ-induced synaptic dysfunction involves NMDA receptor activation
• [Snyder et al., 2005](https://pubmed.ncbi.nlm.nih.gov/15857427/) showed that memantine protects against Aβ toxicity via NMDA modulation

Parkinson's Disease

In PD, NMDA receptors contribute to:

• Excitotoxicity in dopaminergic neurons
• Motor complications from levodopa treatment
• Dysregulation of basal ganglia circuits

Levodopa-Induced Dyskinesia: Chronic levodopa treatment leads to altered NMDA receptor subunit composition and trafficking in the striatum, contributing to abnormal motor responses.

Neuroinflammation: Activated microglia release excitotoxic levels of glutamate, further stimulating NMDA receptors on dopaminergic neurons.

Therapeutic Approaches

NMDA Receptor Antagonists

Memantine

[Memantine - NMDA Antagonist for Alzheimer's Disease](/therapeutics/memantine) is a low-affinity, uncompetitive NMDA receptor antagonist approved for moderate-to-severe AD. Its voltage-dependent block and fast on/off kinetics allow for selective targeting of pathologically activated receptors while sparing normal synaptic transmission.

Clinical Evidence:

• [Reisberg et al., 2003](https://pubmed.ncbi.nlm.nih.gov/12546655/) demonstrated significant cognitive benefits in AD patients
• [Peskind et al., 2006](https://pubmed.ncbi.nlm.nih.gov/16538159/) confirmed safety and efficacy in long-term treatment

Ketamine and Esketamine

Low-dose ketamine shows rapid antidepressant effects in treatment-resistant depression. Research is exploring whether similar mechanisms might benefit neurodegenerative conditions.

Positive Allosteric Modulators

Several compounds enhance NMDA receptor function without affecting glutamate binding:

• D-serine and glycine (co-agonists)
• Synthetic modulators targeting the NR2 subunit

Subunit-Selective Targeting

NR2B-Selective Antagonists: Ifenprodil and related compounds preferentially target NR2B-containing receptors. However, clinical trials for neuroprotection have shown limited success.

NR2A-Selective Modulation: Compounds targeting the NR2A subunit may offer more selective therapeutic effects.

Gene Therapy Approaches

• Viral vector delivery of NMDA receptor subunits
• CRISPR-based editing of GRIN genes
• siRNA-mediated knockdowns of specific subunits

Cross-Linking to Related Mechanisms

Glutamate Receptors

• [AMPA Receptor](/proteins/ampa-receptor): The primary mediator of fast excitatory transmission
• [Kainate Receptor](/proteins/kainate-receptor): Modulates synaptic plasticity

Synaptic Proteins

• [PSD-95](/proteins/psd-95-protein): Scaffolding protein that anchors NMDA receptors
• [CaMKII](/proteins/calmodulin-kinase-ii): Calcium-activated kinase crucial for LTP

Neurodegeneration Pathways

• [Excitotoxicity](/mechanisms/excitotoxicity): Pathological process of excessive glutamate signaling
• [Oxidative Stress](/mechanisms/oxidative-stress): ROS-mediated damage
• [Calcium Dysregulation](/mechanisms/calcium-dysregulation): Disrupted calcium homeostasis

Research Directions

Biomarkers

• NMDA receptor density imaging using PET ligands
• Cerebrospinal fluid biomarkers of NMDA receptor activation
• Electrophysiological markers of NMDA receptor function

Drug Development

• Phenserine derivatives with dual AChE inhibition and NMDA modulation
• NitroMemantine derivatives with enhanced neuroprotective effects
• Novel subunit-selective antagonists with better brain penetration

Pathway & Interaction Diagram

Interactive diagram showing NMDA-RECEPTOR's key relationships in the SciDEX knowledge graph (8 connections shown).

See Also

• [GRIN1 Gene](/genes/grin1)
• [Excitotoxicity](/mechanisms/excitotoxicity)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Calcium Dysregulation](/mechanisms/calcium-dysregulation)

External Links

• [GeneCards: GRIN1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRIN1)

References